Brandon Patrick Goodwin, MD - Medicare Dermatology in Galveston, TX

Brandon Patrick Goodwin, MD is a medicare enrolled "Dermatology" physician in Galveston, Texas. He went to University Of South Alabama College Of Medicine and graduated in 2011 and has 13 years of diverse experience with area of expertise as Dermatology. He is a member of the group practice University Of Texas Medical Branch Faculty Group Practice and his current practice location is 301 University Blvd, Department Of Dermatology, Galveston, Texas. You can reach out to his office (for appointments etc.) via phone at (409) 772-1911.

Brandon Patrick Goodwin is licensed to practice in Texas (license number Q0447) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1730478611.

Contact Information

Brandon Patrick Goodwin, MD
301 University Blvd, Department Of Dermatology,
Galveston, TX 77555-0783
(409) 772-1911
(409) 772-1943



Physician's Profile

Full NameBrandon Patrick Goodwin
GenderMale
SpecialityDermatology
Experience13 Years
Location301 University Blvd, Galveston, Texas
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Brandon Patrick Goodwin attended and graduated from University Of South Alabama College Of Medicine in 2011
  NPI Data:
  • NPI Number: 1730478611
  • Provider Enumeration Date: 03/31/2011
  • Last Update Date: 02/05/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 6204133531
  • Enrollment ID: I20160331000269

Medical Identifiers

Medical identifiers for Brandon Patrick Goodwin such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1730478611NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207ND0900XDermatology - Dermatopathology Q0447 (Texas)Secondary
207N00000XDermatology Q0447 (Texas)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
University Of Texas Medical Branch GalvestonGalveston, TXHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
University Of Texas Medical Branch Faculty Group Practice3375456734875

News Archive

Tailoring care to meet additional needs of hospitalized patients with high social risks

Nurses play a pivotal role in caring for hospitalized patients with social risk factors and preparing them for discharge.

ImmunoCellular develops ICT-107 cell-based vaccine for GBM treatment

ImmunoCellular Therapeutics, a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it has developed an innovative method for manufacturing the company's lead product candidate, ICT-107, a dendritic cell-based vaccine for the treatment of glioblastoma multiforme (GBM).

Researchers develop novel technique for detecting ALK rearrangements in non-small cell lung cancers

Researchers have developed a novel technique for detecting ALK rearrangements in non-small cell lung cancers (NSCLCs) that is more sensitive and easier to perform than currently available techniques.

Bedfont chosen as finalist in 2 categories for KEiBA 2018

The Kent Excellence in Business Awards recognizes companies across Kent and rewards their excellence and achievements.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Brandon Patrick Goodwin allows following entities to bill medicare on his behalf.
Entity NameUtmb Faculty Group Practice
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1942241146
PECOS PAC ID: 3375456734
Enrollment ID: O20031112000438

News Archive

Tailoring care to meet additional needs of hospitalized patients with high social risks

Nurses play a pivotal role in caring for hospitalized patients with social risk factors and preparing them for discharge.

ImmunoCellular develops ICT-107 cell-based vaccine for GBM treatment

ImmunoCellular Therapeutics, a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it has developed an innovative method for manufacturing the company's lead product candidate, ICT-107, a dendritic cell-based vaccine for the treatment of glioblastoma multiforme (GBM).

Researchers develop novel technique for detecting ALK rearrangements in non-small cell lung cancers

Researchers have developed a novel technique for detecting ALK rearrangements in non-small cell lung cancers (NSCLCs) that is more sensitive and easier to perform than currently available techniques.

Bedfont chosen as finalist in 2 categories for KEiBA 2018

The Kent Excellence in Business Awards recognizes companies across Kent and rewards their excellence and achievements.

Read more Medical News

› Verified 9 days ago

Entity NameMotaz Albahra Md Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1306879705
PECOS PAC ID: 3678576006
Enrollment ID: O20060824000276

News Archive

Tailoring care to meet additional needs of hospitalized patients with high social risks

Nurses play a pivotal role in caring for hospitalized patients with social risk factors and preparing them for discharge.

ImmunoCellular develops ICT-107 cell-based vaccine for GBM treatment

ImmunoCellular Therapeutics, a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it has developed an innovative method for manufacturing the company's lead product candidate, ICT-107, a dendritic cell-based vaccine for the treatment of glioblastoma multiforme (GBM).

Researchers develop novel technique for detecting ALK rearrangements in non-small cell lung cancers

Researchers have developed a novel technique for detecting ALK rearrangements in non-small cell lung cancers (NSCLCs) that is more sensitive and easier to perform than currently available techniques.

Bedfont chosen as finalist in 2 categories for KEiBA 2018

The Kent Excellence in Business Awards recognizes companies across Kent and rewards their excellence and achievements.

Read more Medical News

› Verified 9 days ago

Entity NameAdg Houston Path Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1659617009
PECOS PAC ID: 6901283621
Enrollment ID: O20220519000655

News Archive

Tailoring care to meet additional needs of hospitalized patients with high social risks

Nurses play a pivotal role in caring for hospitalized patients with social risk factors and preparing them for discharge.

ImmunoCellular develops ICT-107 cell-based vaccine for GBM treatment

ImmunoCellular Therapeutics, a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it has developed an innovative method for manufacturing the company's lead product candidate, ICT-107, a dendritic cell-based vaccine for the treatment of glioblastoma multiforme (GBM).

Researchers develop novel technique for detecting ALK rearrangements in non-small cell lung cancers

Researchers have developed a novel technique for detecting ALK rearrangements in non-small cell lung cancers (NSCLCs) that is more sensitive and easier to perform than currently available techniques.

Bedfont chosen as finalist in 2 categories for KEiBA 2018

The Kent Excellence in Business Awards recognizes companies across Kent and rewards their excellence and achievements.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Brandon Patrick Goodwin is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Brandon Patrick Goodwin, MD
Po Box 650859, Dept 710,
Dallas, TX 75265-0859

Ph: (409) 772-2222
Brandon Patrick Goodwin, MD
301 University Blvd, Department Of Dermatology,
Galveston, TX 77555-0783

Ph: (409) 772-1911

News Archive

Tailoring care to meet additional needs of hospitalized patients with high social risks

Nurses play a pivotal role in caring for hospitalized patients with social risk factors and preparing them for discharge.

ImmunoCellular develops ICT-107 cell-based vaccine for GBM treatment

ImmunoCellular Therapeutics, a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it has developed an innovative method for manufacturing the company's lead product candidate, ICT-107, a dendritic cell-based vaccine for the treatment of glioblastoma multiforme (GBM).

Researchers develop novel technique for detecting ALK rearrangements in non-small cell lung cancers

Researchers have developed a novel technique for detecting ALK rearrangements in non-small cell lung cancers (NSCLCs) that is more sensitive and easier to perform than currently available techniques.

Bedfont chosen as finalist in 2 categories for KEiBA 2018

The Kent Excellence in Business Awards recognizes companies across Kent and rewards their excellence and achievements.

Read more News

› Verified 9 days ago


Dermatology Doctors in Galveston, TX

Frank Winsett, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 1005 Harborside Dr 5th Floor, Galveston, TX 77555
Phone: 409-747-3376    Fax: 409-772-4456
Dr. Ramon Larrea Sanchez, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 1501 Broadway St, Galveston, TX 77550
Phone: 409-763-2452    Fax: 409-763-2458
Michael George Wilkerson, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 400 Harborside Dr, Galveston, TX 77555
Phone: 409-772-2222    
Janice May Wilson, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 301 University Blvd, University Of Texas Medical Branch-dermatology, Galveston, TX 77555
Phone: 409-772-1911    Fax: 409-772-4456
Richard F Wagner Jr., MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 400 Harborside Dr, Galveston, TX 77555
Phone: 409-772-2222    
Lindy Ross, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 301 University Blvd, Galveston, TX 77555
Phone: 409-772-1911    
Dr. Erica B Kelly, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 301 University Blvd, Galveston, TX 77555
Phone: 409-772-2222    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.